# IGALMI

NDC: 81092-1180
Generic name: DEXMEDETOMIDINE
Labeler / Manufacturer: BioXcel Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: FILM
Routes: SUBLINGUAL
Marketing started: 20220701

FDA application: NDA215390

## Active ingredients

- DEXMEDETOMIDINE: 180 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"81092-1180"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=81092-1180